NDC 55513-150 - BLINCYTO

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
55513-150
Package NDCs from labels
55513-150-01
Manufacturer
Amgen, Inc
Effective date
2026-04-14
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
BLINCYTO - Amgen, IncAmgen, Inc2026-04-14HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55513-150-01BLINCYTO3.088 mL in 1 VIALINJECTION, POWDER, LYOPHILIZED,3.088 mL12.5 ug in 1mL42

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55513-150BLINCYTO (BLINATUMOMAB) KIT [AMGEN, INC]40Unmatched20250511_38b482a8-960b-4591-9857-5031ecb830aa.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BLINATUMOMABACTIVE INGREDIENT4FR53SIF3ABLINCYTO (BLINATUMOMAB) KIT [AMGEN INC]7
BLINATUMOMABACTIVE MOIETY4FR53SIF3ABLINCYTO (BLINATUMOMAB) KIT [AMGEN INC]7
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPBLINCYTO (BLINATUMOMAB) KIT [AMGEN INC]7
LYSINE HYDROCHLORIDEINACTIVE INGREDIENTJNJ23Q2COMBLINCYTO (BLINATUMOMAB) KIT [AMGEN INC]7
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HBLINCYTO (BLINATUMOMAB) KIT [AMGEN INC]7
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IBLINCYTO (BLINATUMOMAB) KIT [AMGEN INC]7
TREHALOSE DIHYDRATEINACTIVE INGREDIENT7YIN7J07X4BLINCYTO (BLINATUMOMAB) KIT [AMGEN INC]7